Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 2
2008 5
2009 4
2010 7
2011 4
2012 5
2013 4
2014 4
2015 7
2016 11
2017 15
2018 16
2019 14
2020 14
2021 26
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

134 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E. Huntington Study Group, et al. Among authors: claassen do. JAMA. 2016 Jul 5;316(1):40-50. doi: 10.1001/jama.2016.8655. JAMA. 2016. PMID: 27380342 Free article. Clinical Trial.
Neurodegeneration and the Cerebellum.
Samson M, Claassen DO. Samson M, et al. Among authors: claassen do. Neurodegener Dis. 2017;17(4-5):155-165. doi: 10.1159/000460818. Epub 2017 May 3. Neurodegener Dis. 2017. PMID: 28463835 Review.
An MDS Evidence-Based Review on Treatments for Huntington's Disease.
Ferreira JJ, Rodrigues FB, Duarte GS, Mestre TA, Bachoud-Levi AC, Bentivoglio AR, Burgunder JM, Cardoso F, Claassen DO, Landwehrmeyer GB, Kulisevsky J, Nirenberg MJ, Rosser A, Roth J, Seppi K, Slawek J, Furr-Stimming E, Tabrizi SJ, Walker FO, Vandenberghe W, Costa J, Sampaio C. Ferreira JJ, et al. Among authors: claassen do. Mov Disord. 2022 Jan;37(1):25-35. doi: 10.1002/mds.28855. Epub 2021 Nov 29. Mov Disord. 2022. PMID: 34842303 Review.
Measuring Functional Status in Huntington's Disease.
Gibson JS, Ridner SH, Dietrich MS, Sohn MB, Rhoten BA, Claassen DO. Gibson JS, et al. Among authors: claassen do. Mov Disord. 2021 Mar;36(3):757-761. doi: 10.1002/mds.28363. Epub 2020 Oct 27. Mov Disord. 2021. PMID: 33108688
Medicolegal Aspects of Huntington Disease.
McDonell KE, Brown BK, Hale L, Darby RR, Stovall J, Compas BE, Claassen DO. McDonell KE, et al. Among authors: claassen do. J Am Acad Psychiatry Law. 2021 Dec;49(4):565-571. doi: 10.29158/JAAPL.210008-21. Epub 2021 Aug 2. J Am Acad Psychiatry Law. 2021. PMID: 34341147
CSF microRNA in patients with Huntington disease.
Claassen DO, Torres-Russotto D. Claassen DO, et al. Neurology. 2018 Jan 23;90(4):151-152. doi: 10.1212/WNL.0000000000004871. Epub 2017 Dec 27. Neurology. 2018. PMID: 29282335 No abstract available.
Risk-Taking Behaviors in Huntington's Disease.
McDonell KE, Ciriegio AE, Pfalzer AC, Hale L, Shiino S, Riordan H, Moroz S, Darby RR, Compas BE, Claassen DO. McDonell KE, et al. Among authors: claassen do. J Huntingtons Dis. 2020;9(4):359-369. doi: 10.3233/JHD-200431. J Huntingtons Dis. 2020. PMID: 33164940
134 results